Accounts filed on 31-03-2021
Accounts filed on 31-03-2021
Registered number: 08954529 | ||||||||
FOR THE YEAR ENDED 31/03/2021 | ||||||||
Prepared By: | ||||||||
Anstee Gorst | ||||||||
Unit 4 Eaton Court | ||||||||
Colmworth Business Park | ||||||||
Eaton Socon | ||||||||
Cambridgeshire | ||||||||
PE19 8ER |
Blair Biomedical Consulting Ltd | ||||||||
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 31/03/2021 | ||||||||
DIRECTORS | ||||||||
REGISTERED OFFICE | ||||||||
Cambridgeshire | ||||||||
COMPANY DETAILS | ||||||||
Private company limited by shares registered in EW - England and Wales, registered number 08954529 | ||||||||
ACCOUNTANTS | ||||||||
Anstee Gorst | ||||||||
Unit 4 Eaton Court | ||||||||
Colmworth Business Park | ||||||||
Eaton Socon | ||||||||
Cambridgeshire | ||||||||
PE19 8ER |
Blair Biomedical Consulting Ltd | ||||||||
ACCOUNTS | ||||||||
FOR THEYEARENDED31/03/2021 | ||||||||
CONTENTS | ||||||||
Page | ||||||||
Directors' Report | - | |||||||
Accountants' Report | - | |||||||
Statement Of Comprehensive Income | - | |||||||
Balance Sheet | 3 | |||||||
Notes To The Accounts | 4 | |||||||
The following do not form part of the statutory financial statements: | ||||||||
Trading And Profit And Loss Account | - | |||||||
Profit And Loss Account Summaries | - |
Blair Biomedical Consulting Ltd | ||||||||
BALANCE SHEET AT | ||||||||||
2021 | 2020 | |||||||||
Notes | £ | £ | ||||||||
FIXED ASSETS | ||||||||||
Tangible assets | 2 | |||||||||
CURRENT ASSETS | ||||||||||
Debtors | 3 | |||||||||
Cash at bank and in hand | ||||||||||
151,240 | 206,535 | |||||||||
CREDITORS: Amounts falling due within one year | 4 | |||||||||
NET CURRENT ASSETS | 160,369 | |||||||||
TOTAL ASSETS LESS CURRENT LIABILITIES | ||||||||||
PROVISIONS FOR LIABILITIES AND CHARGES | 6 | |||||||||
NET ASSETS | ||||||||||
CAPITAL AND RESERVES | ||||||||||
Called up share capital | 7 | |||||||||
Profit and loss account | 125,805 | 163,123 | ||||||||
SHAREHOLDERS' FUNDS | ||||||||||
Approved by the board on | ||||||||||
............................. | ||||||||||
Director | ||||||||||
Blair Biomedical Consulting Ltd | ||||||||
NOTES TO THE ACCOUNTS | ||||||||||
FOR THE YEAR ENDED 31/03/2021 | ||||||||||
1. ACCOUNTING POLICIES |
1a. Basis Of Accounting | ||||||||
The accounts have been prepared under the historical cost convention. | ||||||||
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . |
1b. Depreciation | ||||||||
Land And Buildings | reducing balance 15% | |||||||
Equipment | reducing balance 25% |
2. TANGIBLE FIXED ASSETS | ||||||
Land And | ||||||
Buildings | Equipment | Total | ||||
£ | £ | £ | ||||
Cost | ||||||
At 01/04/2020 | - | 4,729 | 4,729 | |||
Additions | 523 | 1,127 | 1,650 | |||
At 31/03/2021 | 523 | 5,856 | 6,379 | |||
Depreciation | ||||||
At 01/04/2020 | - | 1,205 | 1,205 | |||
For the year | 26 | 1,092 | 1,118 | |||
At 31/03/2021 | 26 | 2,297 | 2,323 | |||
Net Book Amounts | ||||||
At 31/03/2021 | 4,056 | |||||
At 31/03/2020 | 3,524 | |||||
Blair Biomedical Consulting Ltd | ||||||||
3. DEBTORS | 2021 | 2020 | ||||||
£ | £ | |||||||
Amounts falling due within one year | ||||||||
Trade debtors | - | 22,176 | ||||||
Other debtors | - | 1,349 | ||||||
Intercompany | 532 | 2,822 | ||||||
Prepayments | 692 | 656 | ||||||
Directors current account | - | 10,122 | ||||||
1,224 | 37,125 | |||||||
4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
2021 | 2020 | |||||||
£ | £ | |||||||
UK corporation tax | 15,701 | 30,544 | ||||||
VAT | 2,230 | 12,980 | ||||||
PAYE control | 159 | 194 | ||||||
Salaries and wages control | 1,325 | - | ||||||
Directors current account | 169 | - | ||||||
Credit card | 204 | 819 | ||||||
Trade creditors | 159 | 54 | ||||||
Intercompany | 7,518 | - | ||||||
Accruals | 1,250 | 1,575 | ||||||
28,715 | 46,166 | |||||||
5. EMPLOYEES | ||||||
2021 | 2020 | |||||
No. | No. | |||||
Average number of employees | - | |||||
6. PROVISIONS FOR LIABILITIES | 2021 | 2020 | ||||||
£ | £ | |||||||
Deferred taxation | 676 | 670 | ||||||
676 | 670 | |||||||
Blair Biomedical Consulting Ltd | ||||||||
7. SHARE CAPITAL | 2021 | 2020 | ||||||
£ | £ | |||||||
Allotted, issued and fully paid: | ||||||||
100 | 100 | |||||||
100 | 100 | |||||||
8. CONTROLLING PARTY | ||||||||
The controlling party is Edward Blair, director of the company. | ||||||||